FDARulemakingFDA-2011-N-0898
Who commented on this docket
Applications for Food and Drug Administration Approval to Market a New Drug; Revision of Postmarketing Reporting Requirements--Discontinuance
8 organizations filed 8 public comments on Applications for Food and Drug Administration Approval to Market a New Drug; Revision of Postmarketing Reporting Requirements--Discontinuance, at the Food and Drug Administration. The comment window closed 4589d ago.
Organizations
8
Comments
8
RIN
—
Comment window
closed 4589d ago
Commenters (8)
- American Academy of Pediatrics (AAP)1 filing · confidence 97%
- American Hospital Associationtrade assoc.1 filing · confidence 85%
- American Hospital Association AHAtrade assoc.1 filing · confidence 85%
- American Society of Health-System Pharmaciststrade assoc.1 filing · confidence 85%
- American Society of Hematologytrade assoc.1 filing · confidence 85%
- Colon Cancer Alliancetrade assoc.1 filing · confidence 85%
- Pfizer Inc.unverified attribution1 filing · confidence 70%
- the American Dental Association and the American Association of Oral and Maxillofacial Surgeonstrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.